Huntington drug successfully lowers levels of disease-causing protein
An international clinical trial has found that a new drug for Huntington disease is safe and lowers levels of disease-causing protein.
First-of-its-kind imaging facility to accelerate brain research at UBC
The Charles E. Fipke Integrated Neuroimaging Suite is unique, with its PET-MRI machine dedicated solely to brain-related research.
Psychedelics: A new frontier in addiction medicine
The philanthropic community steps up to fill a funding gap in psychedelic-assisted therapy for treating opioid and other substance use disorders.
Common treatment for multiple sclerosis may prolong life
Significant UBC study followed nearly 6,000 patients for more than two decades.
New approach to stroke treatment could minimize brain damage
A new treatment for stroke may soon be possible, thanks to a discovery by an international team of researchers led by UBC.
Motherhood changes the brain, possibly forever
Reproductive experiences may change the trajectory of women’s aging across the lifespan, finds new research from the Djavad Mowafaghian Centre for Brain Health.
Disability progression in multiple sclerosis linked to income, education
The UBC study, led by Helen Tremlett, is the first of its kind.
UBC researchers discover how blood vessels protect the brain during inflammation
Findings could lead to new treatments for neurodegenerative diseases
NFL gives significant funding to help youth ‘shred’ the burden of concussion
UBC researchers involved in groundbreaking pan-Canadian research program.
Lowering levels of Huntington disease-causing protein restores cognitive function in mice
After receiving pieces of DNA called antisense oligonucleotides, the mice also became less anxious and depressed.